McKesson Ventures co-led the first round to be disclosed by the clinical trial services provider, which will put the money into recruitment and improving its technology platform.
US-based clinical trial services provider Lightship closed a$20m series B round on Tuesday that was co-led by McKesson Ventures, the corporate venture capital arm of pharmaceuticals distributor McKesson.
Define Ventures co-led the round, which also featured fellow venture capital firm Khosla Ventures as well as private investors Brook Byers and Marc Benioff. Lightship has not disclosed details of past funding but named Khosla Ventures and Benioff as existing investors.
Founded in 2018, Lightship provides clinical research services with a view…
